12:00 AM
 | 
Aug 05, 2013
 |  BC Week In Review  |  Company News  |  Deals

Stellar Biotechnologies, University of Guelph deal

The university granted Stellar exclusive, worldwide rights to patents and patent applications related to PSII, a polysaccharide found in the cell walls of Clostridium difficile. Stellar will use the IP to develop, manufacture and market human vaccines against C....

Read the full 174 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >